Literature DB >> 2550974

Photosensitization of anticancer agents--8. One-electron reduction of mitoxantrone: an EPR and spectrophotometric study.

K Reszka, J W Lown.   

Abstract

An efficient method of one-electron reduction of the anticancer agent mitoxantrone is described. The method depends on illumination of a suitable photosensitizer absorbing blue light [acriflavine, anthrapyrazole, or Ru(bpy)2+(3)] in the presence of the drug and an electron donor, such as NAD(P)H, in deaerated solutions. An EPR spectrum, assigned to a semiquinone of mitoxantrone, is generated under these conditions and identified by spectral simulation. Decay of this species, attributed to a radical-radical reaction, gives a second order rate constant of 1.7 x 10(2) M-1 s-1 in organic media [dimethylsulfoxide (DMSO)/pH 8 buffer, 1:1 vol/vol] but is more rapid (approximately 10(4) M-1 s-1) in aqueous media under comparable conditions. The considerably decreased lifetime of the mitoxantrone radical at pH 5 is attributed to an additional electron transfer, promoted by protonation of the radical, and/or to an accelerated recombination of neutral radicals, leading to an EPR-silent species. Parallel spectrophotometric studies on the generation of the mitoxantrone reduced species by photosensitized reduction are described. The method offers convenient access to a key radical species involved in the metabolism and possible mode of action of this clinical anticancer agent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550974     DOI: 10.1111/j.1751-1097.1989.tb04163.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  3 in total

1.  Studies of new peroxyoxalate-H2O2 chemiluminescence system using quinoxaline derivatives as green fluorophores.

Authors:  Abdolraouf Samadi-Maybodi; Reza Akhoondi; Mohammad Javad Chaichi
Journal:  J Fluoresc       Date:  2010-03-10       Impact factor: 2.217

2.  Photosensitizing and radiosensitizing effects of mitoxantrone: combined chemo-, photo-, and radiotherapy of DFW human melanoma cells.

Authors:  Ameneh Sazgarnia; Ali Reza Montazerabadi; Mohammad Hossein Bahreyni-Toosi; Amirhossein Ahmadi
Journal:  Lasers Med Sci       Date:  2013-02-01       Impact factor: 3.161

3.  Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells.

Authors:  Birandra K Sinha; Lalith Perera; Ronald E Cannon
Journal:  Biomed Pharmacother       Date:  2019-10-09       Impact factor: 6.529

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.